B. Liu

发表

Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study.

A. Zhou, T. Sun, X.Q. Yan, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

155P Penpulimab combined with anlotinib and nab-paclitaxel plus gemcitabine (PAAG) as first-line treatment for advanced metastatic pancreatic cancer: A prospective, multicenter, single-arm, phase II study

B. Liu, J. Du, F. Tong, 2023, Annals of Oncology.